Synopsys, Inc. $SNPS Shares Sold by Meiji Yasuda Life Insurance Co

Meiji Yasuda Life Insurance Co lessened its stake in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 44.7% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,633 shares of the semiconductor company’s stock after selling 1,320 shares during the period. Meiji Yasuda Life Insurance Co’s holdings in Synopsys were worth $728,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Sankala Group LLC acquired a new position in Synopsys during the 4th quarter worth $25,000. Elevation Wealth Partners LLC increased its position in shares of Synopsys by 96.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after purchasing an additional 27 shares during the last quarter. Osbon Capital Management LLC acquired a new stake in shares of Synopsys in the 2nd quarter valued at about $25,000. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Synopsys in the 4th quarter valued at about $28,000. Finally, IMG Wealth Management Inc. bought a new position in shares of Synopsys during the second quarter worth about $28,000. 85.47% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on SNPS. Bank of America lifted their price target on Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Citigroup upped their price objective on Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Needham & Company LLC reaffirmed a “buy” rating and set a $580.00 target price on shares of Synopsys in a report on Thursday. Stifel Nicolaus lifted their target price on Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Finally, Zacks Research downgraded Synopsys from a “strong-buy” rating to a “hold” rating in a report on Friday, August 21st. Twelve equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $561.28.

View Our Latest Stock Report on SNPS

Synopsys News Summary

Here are the key news stories impacting Synopsys this week:

  • Positive Sentiment: Strong Q3 performance: Synopsys reported adjusted earnings of $3.91 per share versus expectations of $3.67, while revenue reached $2.48 billion, up 42.4% year over year and ahead of estimates. Strength in electronic design automation (EDA) and the Ansys acquisition supported the results. SNPS Q3 Earnings Beat Estimates on EDA and Ansys Strength
  • Positive Sentiment: Higher outlook and AI momentum: Management raised fiscal 2026 guidance, citing accelerating EDA demand, recovering Design IP activity, interest in agentic AI and additional opportunities from integrating Ansys. Fiscal 2026 EPS guidance is $15.04–$15.10, with revenue guidance reportedly raised to approximately $9.72 billion. SNPS Q3 Earnings Call Highlights EDA Acceleration, Outlook Raised
  • Positive Sentiment: Analyst and strategic support: Goldman Sachs, Benchmark and Needham reaffirmed Buy ratings, with price targets ranging from $570 to $600. Elliott Investment Management also reportedly built a multibillion-dollar position, betting Synopsys can narrow its discount to peers. Elliott Bets Multibillion-Dollar Position on Closing Synopsys’ Peer Discount
  • Neutral Sentiment: Commentators view Synopsys as a key supplier to major technology companies, including Nvidia, and believe Ansys has strengthened its competitive moat; however, the acquisition’s full contribution depends on successful integration and future synergies. SNPS in Right Place, Right Time?
  • Negative Sentiment: Valuation and peer concerns: Following the earnings rally, investors are refocusing on valuation, with Synopsys trading at a high earnings multiple. A comparison with PDF Solutions also highlighted stronger growth and margin improvement at the smaller rival, potentially limiting near-term enthusiasm for SNPS. SNPS vs. PDFS: Which Semiconductor Software Stock Has an Edge?

Insiders Place Their Bets

In other news, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the sale, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Company insiders own 0.56% of the company’s stock.

Synopsys Price Performance

Shares of NASDAQ:SNPS opened at $442.61 on Friday. The company has a market cap of $84.82 billion, a PE ratio of 78.20, a P/E/G ratio of 2.60 and a beta of 1.23. Synopsys, Inc. has a fifty-two week low of $366.00 and a fifty-two week high of $615.79. The firm has a 50-day simple moving average of $416.64 and a 200 day simple moving average of $440.13. The company has a quick ratio of 1.32, a current ratio of 1.34 and a debt-to-equity ratio of 0.29.

Synopsys (NASDAQ:SNPSGet Free Report) last issued its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.67 by $0.24. The firm had revenue of $2.48 billion for the quarter, compared to analysts’ expectations of $2.44 billion. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. Synopsys’s revenue was up 42.4% on a year-over-year basis. During the same quarter last year, the company posted $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, sell-side analysts anticipate that Synopsys, Inc. will post 11.03 EPS for the current year.

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Further Reading

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.